208 related articles for article (PubMed ID: 21418073)
1. Are neuroleptic malignant syndrome and serotonin syndrome the same syndrome?
Steele D; Keltner NL; McGuiness TM
Perspect Psychiatr Care; 2011 Jan; 47(1):58-62. PubMed ID: 21418073
[No Abstract] [Full Text] [Related]
2. Serotonin syndrome and atypical antipsychotics.
Duggal HS; Fetchko J
Am J Psychiatry; 2002 Apr; 159(4):672-3. PubMed ID: 11925312
[No Abstract] [Full Text] [Related]
3. Neuroleptic malignant syndrome versus serotonin syndrome: the search for a diagnostic tool.
Sokoro AA; Zivot J; Ariano RE
Ann Pharmacother; 2011 Sep; 45(9):e50. PubMed ID: 21878660
[TBL] [Abstract][Full Text] [Related]
4. [Neuroleptic malignant syndrome].
Bryois C; Bondolfi G
Rev Med Suisse Romande; 1996 Sep; 116(9):713-7. PubMed ID: 8966472
[No Abstract] [Full Text] [Related]
5. [The neuroleptic malignant syndrome in an adolescent. Its treatment with dantrolene, bromocryptin and diazepam].
Real Rodríguez B; Ruibal JL; Grande Rodríguez S; Sueiro Pita B
An Esp Pediatr; 1996 Jan; 44(1):60-2. PubMed ID: 8849063
[No Abstract] [Full Text] [Related]
6. Serotonin syndrome versus neuroleptic malignant syndrome as a cause of death.
Kline SS; Mauro LS; Scala-Barnett DM; Zick D
Clin Pharm; 1989 Jul; 8(7):510-4. PubMed ID: 2568897
[No Abstract] [Full Text] [Related]
7. Neuroleptic malignant syndrome with use of quetiapine in mental retardation.
Dan A; Bharadwaj R; Grover S
Psychiatry Clin Neurosci; 2009 Apr; 63(2):255-6. PubMed ID: 19335404
[No Abstract] [Full Text] [Related]
8. The evaluation and management of patients with neuroleptic malignant syndrome.
Bhanushali MJ; Tuite PJ
Neurol Clin; 2004 May; 22(2):389-411. PubMed ID: 15062519
[TBL] [Abstract][Full Text] [Related]
9. Serotonin syndrome overlapping with neuroleptic malignant syndrome: A case report and approaches for differentially diagnosing the two syndromes.
Nisijima K
Asian J Psychiatr; 2015 Dec; 18():100-1. PubMed ID: 26506919
[TBL] [Abstract][Full Text] [Related]
10. Failed challenge with quetiapine after neuroleptic malignant syndrome with conventional antipsychotics.
Hatch CD; Lund BC; Perry PJ
Pharmacotherapy; 2001 Aug; 21(8):1003-6. PubMed ID: 11718487
[TBL] [Abstract][Full Text] [Related]
11. [Depressive stupor--malignant neuroleptic syndrome--serotonin syndrome. A case contribution to a difficult differential diagnosis].
König F; Löble M; Wolfersdorf M
Nervenarzt; 1996 May; 67(5):407-12. PubMed ID: 9005353
[TBL] [Abstract][Full Text] [Related]
12. Serotonin syndrome and other serotonergic disorders.
Ener RA; Meglathery SB; Van Decker WA; Gallagher RM
Pain Med; 2003 Mar; 4(1):63-74. PubMed ID: 12873279
[TBL] [Abstract][Full Text] [Related]
13. Neuroleptic malignant syndrome and catatonia. A report of three cases.
Raja M; Altavista MC; Cavallari S; Lubich L
Eur Arch Psychiatry Clin Neurosci; 1994; 243(6):299-303. PubMed ID: 7913834
[TBL] [Abstract][Full Text] [Related]
14. Case reports of neuroleptic malignant syndrome in context of quetiapine use.
Detweiler MB; Sullivan K; Sharma TR; Kim KY; Detweiler JG
Psychiatr Q; 2013 Dec; 84(4):523-41. PubMed ID: 23686527
[TBL] [Abstract][Full Text] [Related]
15. Atypical neuroleptic malignant syndrome with quetiapine: a case report and review of the literature.
El-Gaaly S; St John P; Dunsmore S; Bolton JM
J Clin Psychopharmacol; 2009 Oct; 29(5):497-9. PubMed ID: 19745653
[No Abstract] [Full Text] [Related]
16. [The neuroleptic malignant syndrome (NMS). A report of a clinical case with a protracted and recurrent course. A review of the literature].
Marelli A; Bodini P; Dizioli P; Chiodelli G; Guarneri M; Boldori L
Minerva Med; 1996; 87(1-2):45-51. PubMed ID: 8610025
[TBL] [Abstract][Full Text] [Related]
17. Acute myoglobinuric renal failure. A consequence of the neuroleptic malignant syndrome.
Eiser AR; Neff MS; Slifkin RF
Arch Intern Med; 1982 Mar; 142(3):601-3. PubMed ID: 6121542
[TBL] [Abstract][Full Text] [Related]
18. [Neuroleptic malignant syndrome].
Charra B; Nejmi H; Hachimi A; Benslama A; Motaouakkil S
Ann Fr Anesth Reanim; 2006 May; 25(5):542-3. PubMed ID: 16488105
[No Abstract] [Full Text] [Related]
19. Mirtazapine: unable to induce serotonin toxicity?
Gillman PK
Clin Neuropharmacol; 2003; 26(6):288-9; author reply 289-90. PubMed ID: 14646604
[No Abstract] [Full Text] [Related]
20. Adverse reactions to mirtazapine are unlikely to be serotonin toxicity.
Isbister GK; Whyte IM
Clin Neuropharmacol; 2003; 26(6):287-8; author reply 289-90. PubMed ID: 14646603
[No Abstract] [Full Text] [Related]
[Next] [New Search]